-
1
-
-
2342531101
-
Antiviral drugs in current clinical use
-
De Clercq, E. Antiviral drugs in current clinical use, J. Clin. Virol. 2004, 30, 115-133.
-
(2004)
J. Clin. Virol.
, vol.30
, pp. 115-133
-
-
De Clercq, E.1
-
2
-
-
0036050539
-
Strategies in the design of antiviral drugs
-
De Clercq, E. Strategies in the design of antiviral drugs, Nat. Rev. Drug Discov. 2002, 1, 13-25.
-
(2002)
Nat. Rev. Drug Discov.
, vol.1
, pp. 13-25
-
-
De Clercq, E.1
-
3
-
-
0000002872
-
Isopolar phosphorus-modified nucleotide analogues
-
ed. E. De Clercq, Jai Press Inc., London
-
Holy, A., Isopolar phosphorus-modified nucleotide analogues, in Advances in Antiviral Drug Design Vol. 1, ed. E. De Clercq, Jai Press Inc., London, 1993, pp. 179
-
(1993)
Advances in Antiviral Drug Design
, vol.1
, pp. 179
-
-
Holy, A.1
-
4
-
-
0022450584
-
A novel selective broad-spectrum anti-DNA virus agent
-
De Clercq, E.; Holy, A.; Rosenberg, I.; Sakuma, T.; Balzarini, J.; Maudgal, P.C. A novel selective broad-spectrum anti-DNA virus agent. Nature 1986, 323, 464-467.
-
(1986)
Nature
, vol.323
, pp. 464-467
-
-
De Clercq, E.1
Holy, A.2
Rosenberg, I.3
Sakuma, T.4
Balzarini, J.5
Maudgal, P.C.6
-
5
-
-
27844455955
-
Acyclic nucleoside phosphonates: A key class of antiviral drugs
-
a) De Clercq, E.; Holy, A. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat. Rev. Drug Discov. 2005, 4, 928-940.
-
(2005)
Nat. Rev. Drug Discov.
, vol.4
, pp. 928-940
-
-
De Clercq, E.1
Holy, A.2
-
6
-
-
0035997915
-
Cidofovir in the treatment of poxvirus infections
-
b) De Clercq, E. Cidofovir in the treatment of poxvirus infections. Antiviral Res. 2002, 55(1), 1-13.
-
(2002)
Antiviral Res.
, vol.55
, Issue.1
, pp. 1-13
-
-
De Clercq, E.1
-
7
-
-
0037468406
-
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
-
c) Hadziyannis, S.J.; Tassopoulos, N.C.; Heathcote, E.J.; Chang, T.T.; Kitis, G.; et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N. Engl. J. Med. 2003, 348, 800-807.
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 800-807
-
-
Hadziyannis, S.J.1
Tassopoulos, N.C.2
Heathcote, E.J.3
Chang, T.T.4
Kitis, G.5
-
8
-
-
0345138983
-
Phosphonomethoxyalkyl analogs of nucleotides
-
d) Holy, A. Phosphonomethoxyalkyl analogs of nucleotides. Curr. Pharm. Des. 2003, 9(31), 2567-2592.
-
(2003)
Curr. Pharm. Des.
, vol.9
, Issue.31
, pp. 2567-2592
-
-
Holy, A.1
-
9
-
-
75749109023
-
Discovery of GS9148, a novel nucleotide HIV reverse transcriptase (RT) inhibitor
-
Puerto Rico, May 7-11, Elsevier, London
-
Mackman, R.; Boojamra, C.; Chen, J.; Douglas, J.; Grant, D.; et al. Discovery of GS9148, a novel nucleotide HIV reverse transcriptase (RT) inhibitor. Abstract 37, 19th International Conference on Antiviral Research, Puerto Rico, May 7-11, 2006; Elsevier, London.
-
(2006)
19th International Conference on Antiviral Research
, pp. 37
-
-
MacKman, R.1
Boojamra, C.2
Chen, J.3
Douglas, J.4
Grant, D.5
-
10
-
-
2442661557
-
A novel class of phosphonate nucleosides. 9-[(1- phosphonomethoxycyclopropyl)methyl]guanine as a potent and selective anti- HBV agent
-
Choi, J.-R.; Cho, D.-G.; Roh, K.Y.; Hwang, J.-T.; Ahn, S.; et al. A novel class of phosphonate nucleosides. 9-[(1-phosphonomethoxycyclopropyl)methyl] guanine as a potent and selective anti- HBV agent. J. Med. Chem. 2004, 47, 2864-2869.
-
(2004)
J. Med. Chem.
, vol.47
, pp. 2864-2869
-
-
Choi, J.-R.1
Cho, D.-G.2
Roh, K.Y.3
Hwang, J.-T.4
Ahn, S.5
-
11
-
-
0001140507
-
Regiospecific and highly stereoselective electrophilic addition to Furanoid glycols: Synthesis of phosphonate nucleotide analogues with potent activity against HIV
-
Kim, C.U.; Luh, B.Y.; Martin, J.C. Regiospecific and highly stereoselective electrophilic addition to Furanoid glycols: synthesis of phosphonate nucleotide analogues with potent activity against HIV. J. Org. Chem. 1991, 56, 2642-2647.
-
(1991)
J. Org. Chem.
, vol.56
, pp. 2642-2647
-
-
Kim, C.U.1
Luh, B.Y.2
Martin, J.C.3
-
12
-
-
35848933223
-
Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonates
-
Mackman, R.L.; Boojamra, C.G.; Prasad, V.; Zhang, L.; Lin, K.-Y.; et al. Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonates. Bioorg. Med. Chem. Lett. 2007, 17, 6785-6789.
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, pp. 6785-6789
-
-
MacKman, R.L.1
Boojamra, C.G.2
Prasad, V.3
Zhang, L.4
Lin, K.-Y.5
-
13
-
-
38649089790
-
Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131
-
Cihlar, T.; Ray, A.S.; Boojamra, C.G.; Zhang, L.; Hui, H.; Laflamme, G.; et al. Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131. Antimicrob. Agents Chemother. 2008, 52(2), 655-665.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, Issue.2
, pp. 655-665
-
-
Cihlar, T.1
Ray, A.S.2
Boojamra, C.G.3
Zhang, L.4
Hui, H.5
Laflamme, G.6
-
14
-
-
38749083033
-
Synthesis and anti-HIV activity of GS-9148 (2-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor
-
Boojamra, C.G.; Mackman, R.L.; Markevitch, D.Y.; Prasad, V.; Ray, A.S.; et al. Synthesis and anti-HIV activity of GS-9148 (2-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor. Bioorg. Med. Chem. Lett. 2008, 18, 1120-1123.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 1120-1123
-
-
Boojamra, C.G.1
MacKman, R.L.2
Markevitch, D.Y.3
Prasad, V.4
Ray, A.S.5
-
15
-
-
17144400727
-
Deoxythreosyl phosphonate nucleosides as selective anti-HIV agents
-
Wu, T.; Froeyen, M.; Kempeneers, V.; Pannecouque, C.; Wang, J.; et al. Deoxythreosyl phosphonate nucleosides as selective anti-HIV agents. J. Am. Chem. Soc. 2005, 127, 5056-5065.
-
(2005)
J. Am. Chem. Soc.
, vol.127
, pp. 5056-5065
-
-
Wu, T.1
Froeyen, M.2
Kempeneers, V.3
Pannecouque, C.4
Wang, J.5
-
16
-
-
33846908126
-
Synthesis of 3-O-phosphonomethyl nucleosides with an adenine base moiety
-
Vina, D.; Wu, T.; Renders, M.; Laflamme, G.; Herdewijn, P. Synthesis of 3 -O-phosphonomethyl nucleosides with an adenine base moiety. Tetrahedron 2007, 63, 2634-2646.
-
(2007)
Tetrahedron
, vol.63
, pp. 2634-2646
-
-
Vina, D.1
Wu, T.2
Renders, M.3
Laflamme, G.4
Herdewijn, P.5
-
17
-
-
0017521195
-
Reactions of relevance to the chemistry of aminoglycoside antibiotics. Part 7. Conversion of thiocarbonates into deoxy-sugars
-
a) Barton, D.H.; Subramanian, R. Reactions of relevance to the chemistry of aminoglycoside antibiotics. Part 7. Conversion of thiocarbonates into deoxy-sugars. J. Chem. Soc., Perkin Trans. 1 1977, 15, 1718-1723.
-
(1977)
J. Chem. Soc. Perkin Trans. 1
, vol.15
, pp. 1718-1723
-
-
Barton, D.H.1
Subramanian, R.2
-
18
-
-
0344902741
-
A new method for the deoxygenation of secondary alcohols
-
b) Barton, D.H.; McCombie, S.W. A new method for the deoxygenation of secondary alcohols. J. Chem. Soc., Perkin Trans 1 1975, 16, 1574-1585.
-
(1975)
J. Chem. Soc. Perkin Trans 1
, vol.16
, pp. 1574-1585
-
-
Barton, D.H.1
Mc Combie, S.W.2
-
19
-
-
0037809239
-
Inhibition of hepatitis C virus RNA replication by 2-modified nucleoside analogs
-
Carroll, S.S.; Tomassini, J.E.; Bosserman, M.; Getty, K.; Stahlhut, M.W.; Eldrup, A.B.; et al. Inhibition of hepatitis C virus RNA replication by 2-modified nucleoside analogs. J. Biol. Chem. 2003, 278(14), 11979-11984.
-
(2003)
J. Biol. Chem.
, vol.278
, Issue.14
, pp. 11979-11984
-
-
Carroll, S.S.1
Tomassini, J.E.2
Bosserman, M.3
Getty, K.4
Stahlhut, M.W.5
Eldrup, A.B.6
|